BridgeBio Pharma, Inc. Prices Upsized Offering Of $650 Million Convertible Senior Notes

Monday, January 25, 2021 1 min read

Key Takeaway: BridgeBio Pharma, Inc. Prices Upsized Offering Of $650 Million Convertible Senior Notes

Full Press Release Details

BridgeBio Pharma, Inc. Prices Upsized Offering Of $650 Million Convertible Senior Notes.